Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 12, 2026) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces that Lower Antino has been upgraded from Intermediate to Advanced Target status - the same internal classification* as Upper Antino - at its Antino Gold Project in southeastern Suriname (Figure 1). The upgrade follows cumulative drilling of 50 diamond drill holes including eight new holes reported here that continue to demonstrate broad, continuous gold mineralization, highlighted by 65.9 metres (m) of 1.16 grams per tonne (g/t) gold (Au) within a broader envelope of 115.0 m of 0.83 g/t Au from surface in drill hole LA046.HighlightsLower Antino upgraded to Advanced Target status with 50 drill holes released to date with an additional 10 holes pending assays and further expansion drilling underwayBest intercept to date: 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au from surface (LA046)Broad mineralized envelopes confirmed: 113.5 m of 0.34 g/t Au from surface including 30.0 m of 0.82 g/t Au (LA044)Intrusion-hosted gold mineralization intersected in all eight drill holes reported in this release; mineralization remains open along strike and at depthColin Padget, President & CEO, commented, "Lower Antino's upgrade from Intermediate to an Advanced Target - now sharing the same classification as Upper Antino - reflects consistent, broad gold mineralization across a growing number of drill holes. LA046 returning 65.9 metres of 1.16 g/t gold within a 115-metre mineralized envelope is the best intercept to date at this target and underscores the scale and continuity of the Lower Antino intrusion-hosted gold system. With gold in every hole and consistently wide intercepts, Lower Antino is emerging as a meaningful contributor to the district's overall potential. While our focus remains on exploration and expansion drilling, Lower Antino's advancement to the same classification as Upper Antino means it is expected to be considered for inclusion in any future resource estimate for the district."Lower Antino - Upgraded to Advanced TargetThe Company reports assay results from eight diamond drill holes (LA043 to LA050) at the Lower Antino target, located approximately 3.5 km east of the Upper Antino deposit (Figure 1). All eight holes intersected gold mineralization, with results highlighted by 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au in LA046 (Table 1). The 115-metre intercept in LA046 begins at surface and represents an up-dip expansion of the previously released 90.0 m of 1.02 g/t Au in LA041, confirming the continuity and growth potential of the mineralized zone.Based on cumulative drilling results, Founders has upgraded Lower Antino from Intermediate Target to Advanced Target status, ranking it on the same tier as Upper Antino in terms of overall target quality and scale potential. The upgrade reflects the demonstrated continuity of gold mineralization across numerous drill sections and identification of multiple parallel, northeast-trending mineralized zones over approximately 1.9 km of drill-defined strike length within a broader 1.5 km by 2.8 km gold-in-auger anomaly.The target is open along strike and at depth with drilling ongoing to the south and southeast at regular 100 to 200 metre steps. Overall, gold mineralization remains consistent with previous Lower Antino drill results and is hosted in intensely sericite-altered, sheared tonalite with disseminated pyrite and quartz-pyrite veining. The southernmost hole in this release (LA050), intersected 24.0 m of 0.57 g/t Au and represents approximately 200 metres of southward expansion of the mineralized system. Assay results are presented in Table 1, with drill hole locations in Table 2.Lower Antino is one of two Advanced Targets within Founders' 102,360-hectare contiguous land package, which hosts eight drill tested gold targets across the 55 km long Antino concession. The upgrade of Lower Antino adds meaningful scale to the Company's growing inventory of drill-defined gold mineralization at the district level. The Company will continue to systematically advance and upgrade high-quality targets as defined by geological criteria linked to scale and growth potential.*The Company's internal target classification system reflects drill density, demonstrated continuity of mineralization, and data sufficiency; it does not correspond to NI 43-101 resource categories.Figure 1: Antino Gold Project Property MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_001full.jpgFigure 2: Lower Antino Plan MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_002full.jpgFigure 3: Lower Antino cross-section through central gold trend.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_003full.jpgTable 1: Lower Antino Drill ResultsDrillholeFrom (m)To (m)Interval (m)Au (g/t)Results from This ReleaseLA043162.00174.0012.001.56incl.167.00174.007.002.56LA0441.50115.00113.500.34incl.8.1038.1030.000.82LA0450.0020.1020.100.31and111.00124.0013.000.44LA0460.00115.00115.000.83incl.41.10107.0065.901.16LA0470.008.108.100.94and149.00156.007.000.46LA0480.0027.6027.600.22and173.00178.005.000.80LA0496.6011.104.500.21LA05047.1071.1024.000.57Previously Released Highlight ResultsLA041156.00246.0090.001.02incl.176.00178.002.0028.44LA00374.10156.0081.901.00incl.106.00132.0026.002.36LA0250.00241.00241.000.27incl.0.0086.1086.100.43LA03329.1060.0030.901.56LA02472.00122.0050.001.02LA028108.00163.0055.000.64incl.110.00117.007.002.32LA0190.0065.0065.000.49incl.44.1065.0020.901.11LA01033.6057.6024.001.23 **Intervals are down-hole depths. True widths of mineralization are estimated to be approximately 85% of the down-hole interval based on currently available results and observations. All are diamond drill holes. Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts. Composites are calculated using a 0.10 g/t Au cut-off grade with

Results Highlights:Revenue increased by 10.0% year-on-year to a record high of US$180.5 million, marking the fifth consecutive year of record-setting revenue performance.Sales volume hit a new high of 2.02 million units, representing a year-on-year increase of 16.2%.Gross profit rose by 7.0% to a record of US$122.4 million; profit attributable to owners of the Company rose by 5.5% to US$41.9 million.The Board has proposed a final cash dividend of HK12 cents per share, bringing the total cash dividend for the Year to HK27 cents per share alongside special dividend, representing a payout ratio of 68.4%.The Group remains in a robust financial position, with cash and bank balances of US$228.7 million at the end of the year for supporting potential acquisitions and the construction of new production facilities.Maintained revenue growth in major markets, with the Asia-Pacific market at 15.7%, the EMEA markets at 19.6%, and the US market at 37.0%.The Group actively leverages its sales network and expertise to assist high-quality medical device peers in selling their products globally, while diversifying its own product portfolio. One of the collaborative products has already been launched in Hong Kong, Malaysia, Germany, and Spain, and is progressively being rolled out to more markets in the APAC and EMEA regions.HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, today announced its annual results for the year ended December 31, 2025 (“FY2025” or the “Year”). Despite significant external challenges, the Group demonstrated remarkable resilience, achieving historic highs in revenue, sales volume, and gross profit, along with improved net profit.During the Year, OrbusNeich’s investments to strengthen its global sales and marketing capabilities, as well as expand product offerings, continued to yield positive results. The Group achieved revenue growth for the fifth consecutive year, reaching a record high of US$180.5 million. Additionally, sales volume in FY2025 hit a new high of 2.02 million units, representing a year-on-year growth of 16.2%, which included an increase of 13.1% from proprietary products and 34.9% from third-party products. Gross profit, up by 7.0% year-on-year, reached a record high of approximately US$122.4 million, with profit attributable to owners of the Company increasing by 5.5% to $41.9 million, and basic earnings per share rising by 5.8% to US5.09 cents.As at December 31, 2025, the Group maintained a strong financial position with cash and bank balances amounting to US$228.7 million. Taking into consideration OrbusNeich’s solid operating performance, healthy cash reserves and future capital requirements, the Board has proposed a final cash dividend of HK12 cents per share (2024: HK10 cents per share), up by 20% year-on-year. Alongside the special cash dividend of HK15 cents per share paid during the Year to celebrate OrbusNeich’s 25th anniversary and express gratitude for shareholders’ long-standing support, the total cash dividend for FY2025 will be HK27 cents per share.Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, “Building on 25 years of expertise, OrbusNeich achieved another strong performance in FY2025. Our commitment to product innovation and quality, and the establishment of dedicated local teams in diverse markets ensures that our products benefit vascular disease patients worldwide. During the Year, the Group advanced its strategy of building a comprehensive sales network while forging strategic collaborations, including providing commercialization support for Chinese medical device companies expanding overseas. Meanwhile, construction of our R&D and manufacturing base in Hangzhou is progressing steadily, reflecting our long-term growth ambitions.”Extensive Global Sales Network Fuels Strong Multi-Regional Revenue and Business GrowthOrbusNeich maintains an extensive sales network covering over 70 countries and regions through its 12 direct sales teams and distributor network, which includes the acquisition of a Taiwan-based distributor during the Year. During FY2025, the APAC region experienced a significant year-on-year increase in revenue of 15.7%, climbing to US$60.5 million, driven by strong performance in existing direct sales markets and the addition of the Taiwan market. Revenue growth in the EMEA region accelerated, rising by 19.6% to US$46.9 million, supported by rapid growth of over 20% in direct sales markets such as Germany, France, and Spain, along with substantial growth in distributor markets. As the impact of tariffs eased and product demand remained strong, revenue from the US market grew by 37.0% year-on-year, reaching US$21.2 million. Meanwhile, revenue from the Japan and PRC markets totaled US$32.3 million and US$17.8 million, respectively.In the second half of the year, the Group focused on strengthening its market presence in Europe and established a direct sales team in the Netherlands. The Group is establishing another direct sales team in Belgium in 2026, with the goal of achieving direct sales to local hospitals in both markets within the same year.OrbusNeich’s robust global sales network has attracted various manufacturers to collaborate with the Group on international market expansion. During the Year, the Group strengthened its partnership with SonoScape Medical Corp. by distributing their IVUS products across key APAC and European markets, including direct sales regions like Singapore, Malaysia, France, Germany, Spain, and Switzerland, as well as selected distributor markets in Europe. The IVUS products began generating sales in Hong Kong, Malaysia, Germany, and Spain by the end of FY2025.Strengthening a Diversified Portfolio via Parallel Global Registrations and Clinical TrialsAs at December 31, 2025, OrbusNeich owned more than 220 granted patents and published patent applications in key jurisdictions worldwide, as well as 35 PMDA-approved products, 42 CE-marked products, 20 FDA-cleared or approved products, and 24 NMPA-approved products.During the Year, the Group achieved progress in product registrations and clinical trials, including:Obtained PMDA approvals for Teleport Glide, Scoreflex QUAD, EZGuide LL (Large Lumen), Vascuaid and SIDEPASS, CE Marks for JADE PLUS and Teleport Glide, and NMPA approvals for the GuidingArk guiding catheter and Teleport XT;Submitted applications for FDA approval of Teleport Glide, PMDA approvals of Sapphire ULTRA and Sapphire NC ULTRA, and NMPA approvals of Scoreflex TRIO, Teleport Glide, Sapphire NC 24, Sapphire NC ULTRA, Sapphire ULTRA and JADE PLUS;Completed patient enrollment for the US clinical trial of Sapphire 3, with product registration expected to be submitted to the FDA in the first half of 2026;Completed patient enrolment of clinical registries for eucatech AG’s product eucaLimus and SUPPORT C, while patient enrollment for VITUS is still ongoing, with the goal of renewing CE Marks for these products under MDR by the end of 2027;Developing the proprietary coronary paclitaxel drug-coated balloon, Sapphire PTX, with a clinical trial application expected to be submitted to the PMDA in Q1 2026;Developing the peripheral scoring balloon, JADE Score, with registration applications expected to be submitted to the PMDA and the FDA in 2026.Optimizing Global Production Layout for Sustained Long-Term GrowthThe Group’s facilities in Shenzhen, the PRC; Hoevelaken, the Netherlands; and Weil am Rhein, Germany, achieved a combined annual production capacity of approximately 2.1 million units of balloons and stents as at December 31, 2025. To meet future production needs, construction of OrbusNeich’s largest R&D and manufacturing facility in Hangzhou, the PRC, is underway. Following the topping-out ceremony in the second half of 2025, marking the completion of construction of the main structure, renovation work has been ongoing since the end of 2025. The new facility is expected to commence operation in 2027, adding an annual production capacity of 2.4 million units.Mr. Chien concluded, “Looking ahead to 2026, OrbusNeich will continue leveraging its global platform to navigate ongoing external challenges. With the launch of new proprietary and eucatech AG products, rising third-party product sales, and the shift from distribution model to direct sales in certain markets, we expect steady revenue growth in the future. The Group will also explore potential downstream acquisitions in Europe to further consolidate our brand position. Going forward, we aim to sharpen our commercialization edge, maintain leadership in innovation and quality, and explore new business models to drive growth. Ultimately, these initiatives will reinforce our global competitiveness and further our founder, Mr. Teddy Chien’s vision of ‘benefitting humanity’ by improving patients’ quality of life worldwide.”About OrbusNeich Medical Group Holdings LimitedOrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.For more information, please visit the Group’s official website: https://orbusneich.com/.Media InquiriesStrategic Financial Relations LimitedAngelus LauTel: (852) 2864 4805Email: angelus.lau@sprg.com.hkDoris HoTel: (852) 2114 4916Email: doris.ho@sprg.com.hkBailey ZhouTel: (852) 2114 2825Email: bailey.zhou@sprg.com.hkWebsite: https://www.sprg.com.hk/OrbusNeich Medical Group Holdings Limited Maggie LauTel: (852) 3109 7234Email: mlau@orbusneich.comLucille Tsang Tel: (852) 3109 7292Email: ltsang@orbusneich.comWebsite: https://orbusneich.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

业绩亮点：收入同比增长10.0%至1.80亿美元，连续五年创新高。销量破纪录，达202万件，同比增长16.2%。毛利上升7.0％至1.22亿美元新高；公司拥有人应占利润增长5.5%至约4,190万美元。董事会建议派发末期股息每股12港仙，连同特别股息，本年度现金股息总额达每股27港仙，派息比率为68.4％。财务状况稳健，年末现金及银行结余为约2.29亿美元，支持潜在收购及新生产设施建设。主要市场收入继续增长，亚太地区市场增长15.7％，欧洲、中东及非洲市场增长19.6%，及美国市场增长37.0%。集团积极透过其销售网络及专业知识，协助优质医疗器械同业的产品迈向全球，同时丰富自身的产品组合。其中一款合作产品已于香港、马来西亚、德国及西班牙上市，并正逐步推广至亚太及欧洲、中东及非洲地区更多市场。香港, 2026年3月12日 - (亚太商讯 via SeaPRwire.com) - 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司（"业聚医疗"或"集团"；股份代号：6929）今天宣布截至2025年12月31日止年度（"2025财政年度"或"回顾年"）的全年业绩。尽管外围环境充满挑战，集团仍展现非凡韧性，收入、销量及毛利齐创历史新高，纯利亦录得增长。回顾年内，业聚医疗在强化全球销售与营销能力及扩大产品组合投资方面，继续取得显著成效。集团收入连续五年实现增长，达180.5百万美元新高。2025财政年度销量亦创新高，同比增长16.2%至202万件，其中自有产品及第三方产品销量分别增长13.1%及34.9%。毛利同比增长7.0％至122.4百万美元，同创历史高位；公司拥有人应占利润增长5.5%至41.9百万美元。每股基本盈利上升5.8%至5.09美仙。于2025年12月31日，集团的财务状况维持稳健，现金及银行结余达约228.7百万美元。鉴于业聚医疗稳健的营运表现、充裕的现金储备及考虑到未来资本需求，董事会建议派发末期现金股息每股12港仙（2024年：每股10港仙）。连同较早前为庆祝业聚医疗成立25周年及答谢股东长期支持而派发的每股15港仙特别现金股息，2025财政年度的现金股息总额为每股27港仙。业聚医疗董事长、执行董事兼首席执行官钱永勋先生表示："业聚医疗凭借过去25载建立的实力，于2025财政年度再创佳绩。我们一直坚持产品创新与品质至上的承诺，并建立专业团队扎根全球各主要市场，确保产品可惠及世界各地的血管疾病患者。本年度，集团持续扩展全球销售网络，同时推进多项策略性合作，包括为期望进军海外市场的中国医疗器械企业提供商业化支持。同时，我们位于杭州的研发及生产基地建设进展顺利，充分展现集团寻求长远增长的决心。"销售网络遍及全球，推动多区域收入及业务强劲增长业聚医疗的庞大销售网络，是由12个直销团队（包括本年度收购的一家台湾分销商）及分销商网络组成，遍及全球70多个国家和地区。2025财政年度，有赖现有直销市场的强劲表现及台湾市场的额外贡献，亚太地区收入同比大幅增长15.7%至60.5百万美元；欧洲、中东及非洲地区方面，德国、法国及西班牙等直销市场录得逾20.0%的快速增长，分销商市场亦增长显著，带动该区整体收入加速增长，上升19.6%至46.9百万美元。而随关税影响缓解加上产品需求持续强劲，美国市场收入同比增长37.0%至21.2百万美元。而日本及中国内地市场的收入分别为32.3及17.8百万美元。下半年，集团重点强化欧洲市场布局，在荷兰建立了直销团队。2026年，集团正于比利时设立另一直销团队，以期在同年于两地市场实现向医院直销。业聚医疗广泛的全球销售网络吸引了众多制造商携手合作，共同拓展国际市场。本年度，集团深化与深圳开立生物医疗科技股份有限公司的合作，于多个亚太及欧洲主要市场分销其血管内超声（IVUS）产品，涵盖新加坡、马来西亚、法国、德国、西班牙、瑞士等直销市场，以及欧洲数个选定的分销市场。于2025财政年底前，该产品已于香港、马来西亚、德国及西班牙市场实现销售。全球注册与临床齐头并进，强化多元创新产品组合截至2025年12月31日，业聚医疗在全球主要司法管辖区拥有超过220项授权专利及已公布专利申请，包括35款获PMDA批准产品、42款获CE标志产品、20款获FDA许可产品及24款获国家药监局批准产品。本年度，集团在产品注册及临床试验方面继续取得进展，包括：Teleport Glide、Scoreflex QUAD、EZGuide LL（大管腔）、Vascuaid及SIDEPASS获PMDA批准，JADE PLUS及Teleport Glide获CE标志，GuidingArk导引导管及Teleport XT获国家药监局批准；就Teleport Glide向FDA提交检准申请、就Sapphire ULTRA及Sapphire NC ULTRA向PMDA提交批准申请；就Scoreflex TRIO、Teleport Glide、Sapphire NC 24、Sapphire NC ULTRA、Sapphire ULTRA及JADE PLUS向国家药监局提交批准申请；完成Sapphire 3美国临床试验的病人入组工作，预计于2026年上半年向FDA提交产品注册申请；完成eucatech AG旗下产品eucaLimus及SUPPORT C的临床登记的病人入组，并进行VITUS的病人入组工作，目标于2027年底前取得MDR下的CE标志认证；开发自有冠状动脉紫杉醇药物涂层球囊Sapphire PTX，预计于2026年第一季向PMDA提交临床试验申请；开发外周刻痕球囊JADE Score，预计于2026年向PMDA及FDA提交注册申请。优化全球产能布局，实现可持续的长远增长集团位于中国深圳、荷兰荷佛拉肯及德国莱茵河畔魏尔的生产设施，于2025年12月31日的球囊及支架年产能达约210万件。为满足未来生产需要，集团正于中国杭州兴建旗下最大型的研发及生产设施。项目封顶仪式已于2025年下半年举行，标志该设施主体结构工程竣工，装修工程亦于2025年底启动。新设施预计于2027年投入营运，届时将新增年产能240万件。钱先生总结："展望2026年，业聚医疗将继续善用全球平台应对当前外围挑战。随着自有新产品及eucatech AG产品推出、第三方产品销量持续增长，以及部分市场由分销转向直销模式，我们预期未来收入将稳步上升。集团亦将于欧洲物色潜在的下游收购目标，以进一步巩固品牌地位。未来，我们将继续强化商业化方面的竞争优势，保持产品创新与卓越品质方面的领先地位，并积极探索新业务发展模式，以达致增长。这些举措不仅能巩固集团的全球竞争力，更将延续创始人钱学雄先生‘造福人群’的初心与使命，为全球患者带来更美好的生活。"关于业聚医疗集团控股有限公司业聚医疗是一家全球医疗器械制造公司，专门生产用于经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）的介入器械。本集团总部位于中国香港，产品销往全球超过70个国家和地区。集团亦积极将业务扩展至结构性心脏病领域。凭借拥有逾20年产品开发经验的内部研发团队，本集团已开发出世界领先的专有技术。如需了解详情，请访问集团官网：https://orbusneich.com/传媒垂询纵横财经公关顾问有限公司刘若琪电话：(852) 2864 4805电邮：angelus.lau@sprg.com.hk 何田田电话：(852) 2114 4916电邮：doris.ho@sprg.com.hk周百霖电话：(852) 2114 2825电邮：bailey.zhou@sprg.com.hk 网站: www.sprg.com.hk业聚医疗集团控股有限公司刘慧菁电话：(852) 3109 7234电邮：mlau@orbusneich.com曾 璐电话：(852) 3109 7292电邮：ltsang@orbusneich.com网站: https://orbusneich.com/ Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – As the average age of the global population continues to rise, the Chinese Mainland is now home to the world’s largest number of seniors. Recognising this, the country’s 15th Five-Year Plan calls for proactive measures to address the challenges of an increasingly ageing population. The silver economy is set to be one of the vital engines for the mainland's next wave of economic growth.The Hong Kong Trade Development Council (HKTDC) has released a new consumer survey report, Chinese Mainland Silver Economy Opportunities, that details the strong spending power of the mainland’s affluent, middle-class senior consumers, as well as the vast untapped potential of this particular sector of society. With securing "happiness" and ensuring "quality" as their spending priorities, the survey shows that such consumers regard Hong Kong-made products as guaranteed to be authentic, while the city’s services sector is seen as professional and reliable. As a result, many of these consumers pronounce a willingness to pay a "Hong Kong premium".Believing that the continued expansion of the mainland's silver economy represents significant opportunities for Hong Kong businesses, Bruce Pang, HKTDC Director of Research, said: "Among other priorities, the 15th Five-Year Plan focuses on boosting domestic demand as a means of driving economic growth. Inevitably, this will create opportunities for Hong Kong companies looking to expand into the Chinese Mainland market.“By gaining a deeper understanding of the consumption patterns of mainland seniors, particularly those in the higher-spending middle-class and affluent segments, Hong Kong businesses will be able to effectively penetrate the domestic market."To gain a more in-depth understanding of the development opportunities in the country’s silver economy, HKTDC surveyed more than 2,000 middle-class/affluent senior consumers in various mainland cities last year. The broad cross-section of respondents included those in their 50s starting to plan their retirement, those entering retirement in their 60s, and the older post-retirement population (aged 70 and above). According to the survey’s findings, respondents' average monthly expenditure on daily consumer goods and services was approximately RMB7,000, rising to RMB8,000 for those in first-tier cities.Commenting on the findings of the survey, Wing Chu, the HKTDC’s Deputy Director of Research, who led the study, said: "Currently, the Chinese Mainland's silver economy is valued at about RMB7 trillion – some 6% of overall GDP. This is projected to surge to RMB30 trillion by 2035, indicating the segment’s huge development potential.“The survey also showed that more than half of such consumers had purchased Hong Kong products or services, consequently holding Hong Kong brands in particularly high regard. It was also notable that 78% of respondents were willing to pay a premium for Hong Kong-sourced products, while 84% were willing to do so in the case of the city’s services sector. Typically, respondents were willing to pay a 16.4% premium on products and 15.4% premium on services, with those in first-tier cities happy to pay an even higher percentage for many types of products and services.”Hong Kong brands enjoy stellar reputationOverall, many of the mainland’s senior consumers have a highly positive view of Hong Kong brands, with the city’s products celebrated for their quality and authenticity, and its services for their professionalism and reliability. On the product front, 61% of respondents had purchased Hong Kong products in the past year, including health foods (24%), luxury goods (18%) and beauty and personal care products (17%). In terms of future purchases, respondents expressed the greatest interest in Hong Kong health foods, leisure foods and beverages.Regarding the city’s services, 54% of senior respondents said they had utilised Hong Kong services in the past year, including beauty and personal care services (25%), travel to Hong Kong, Macao and Taiwan (22%) and financial and wealth management services (20%). Over the next 12 months, the most sought-after Hong Kong services were said to relate to health and wellness services, followed by beauty and personal care services.Digging deeper into the preferences of such consumers, HKTDC Economist Eric Chu said: "When choosing products and services, happiness is the priority for Chinese Mainland seniors, closely followed by value for money. With this in mind, Hong Kong businesses can leverage the silver economy by capitalising on the strong reputation and professional advantages of the city’s brands.“Specifically, they should consider expanding into the higher-spending first and second-tier cities, while targeting the younger segment of the senior population. Enhancing the offline experience and fostering word-of-mouth recommendations, alongside optimised promotional efforts, will also help Hong Kong businesses stand out in the mainland’s rapidly growing silver market.”Silver generation shaping a “blue ocean” of consumptionTaking a more in-depth look at the survey findings, 65% of respondents prioritised products or services that would enhance their leisure or bring them happiness, while 63% valued reasonable pricing and good value for money, and 62% focused more on the practicality and durability of the products or services on offer. Collectively, this indicates that mainland seniors are particularly concerned about their health and quality of life, while also valuing cost-effectiveness and functionality, marking them out as a notably mature and rational consumer group.In terms of product consumption, 23.3% of respondents most frequently purchased food and beverages, followed by home products (12.6%) and clothing (12.5%). In the case of services, 20.3% utilised body wellness services most often, followed by beauty and personal care services (16.7%) and leisure and entertainment services (13.1%).In addition, despite the popularity of online shopping across the mainland, the survey showed that physical stores remain the primary consumption channel for the more elderly demographic. For such consumers, offline experiences, in-person consultations and a sense of trust in products and services remain prime considerations.To help businesses capitalise on opportunities arising from the silver economy market, the HKTDC has incorporated various related elements into many of its exhibitions and forums. This allows relevant companies to showcase their products and technologies, while also giving them the opportunity to explore the latest industry developments through a series of related seminar programmes.Aligning with this approach, a thematic seminar on healthy ageing was held as part of the Asia Summit on Global Health, while the Rehabilitation and Elderly Care zone at the Hong Kong International Medical and Healthcare Fair featured the latest gerontechnology products. The Hong Kong Electronics Fair (Autumn Edition) also sought to showcase fitness and health products relevant to the senior market.In addition, the Hong Kong Toys & Games Fair, held in January this year, introduced a new “Happy Ageing” label for silver market products, making it easier for buyers to identify toys and related products designed specifically for older consumers. The Asia Toys & Games Forum, held during the fair, hosted a discussion by a number of international experts on the optimum design of toys for the elderly, while also offering many other insights into the silver-focused toy market.Looking ahead, the HKTDC will continue to provide comprehensive support to the business sector, enabling enterprises to further explore and develop opportunities in the growing silver economy market.ReferencesReport link: https://research.hktdc.com/en/article/MjI2ODIyMDg0NwHKTDC Research: http://research.hktdc.com/enPhoto download: https://bit.ly/4shpQjOHKTDC Director of Research Bruce Pang (centre), Deputy Director of Research Wing Chu (left) and Economist Eric Chu (right) presented key findings from the "Chinese Mainland Silver Economy Opportunities" consumer survey reportHKTDC Media Room: http://mediaroom.hktdc.com/enMedia enquiriesFor enquiries, please contact:Raconteur PR Agency:Betsy TseTel: (852) 9742 7338Email: betsytse@raconteur.hkMolisa LauTel: (852) 6187 7786Email: molisalau@raconteur.hkHKTDC Communication and Public Affairs Department:Clayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – Mint Incorporation Limited (“Mint” or the “Group”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, today announced that its wholly-owned subsidiary, Axonex Intelligence Limited (“AXONEX”) has entered into a joint venture agreement (the “JV Agreement”) with Synergy Technology Group Limited (“STG”) to establish Axonex Automation Limited (“JV company”), a new Hong Kong-based joint venture company focused on commercializing advanced digital twin and drone flight control technologies in Hong Kong and selected overseas markets.Under the JV Agreement, AXONEX will hold an 80% equity interest in Axonex Automation Limited, while STG will hold the remaining 20%. The joint venture will combine AXONEX’s operational resources and international business capabilities with STG’s proven technology in digital twins and drone flight control systems to drive scalable deployment in sectors such as infrastructure inspection, utilities, smart cities, and industrial operations.AXONEX has committed to provide up to HK$ 20,000,000 of capital to the joint venture in stages, subject to the achievement of defined business and technical milestones set out in the agreement. The funding will be released through four tranches over an expected 12–24-month period.STG will contribute technology, intellectual property, know-how, and ongoing technical support to the JV company, initially via a license of its core digital twin and drone flight control platforms, the “Zhishan No-Code Digital Twin Universal Platform and related drone inspection technologies” to Axonex Automation Limited.Mr. Damian Chan, Chairman of the Board and Chief Executive Officer of Mint stated: “This joint venture creates a focused vehicle to bring next-generation digital twin and autonomous drone capabilities from concept to commercial reality across Hong Kong and key overseas markets.”A representative of Synergy Technology Group Limited added: “Our collaboration with AXONEX will accelerate the real-world adoption of our digital twin and drone flight control technologies in critical infrastructure, smart city, and industrial applications, leveraging Hong Kong as a launchpad for global expansion.”Photo CaptionMr. Damian Chan, Chairman of the Board and Chief Executive Officer of Mint (Right) and Mr. Jiang Xiaotong, founder of STG (Left) signed the JV to establish Axonex Automation Limited focused on commercializing advanced digital twin and drone flight control technologies in Hong Kong and selected overseas markets.About Mint Incorporation LimitedMint Incorporation Limited (NASDAQ: MIMI), a Hong-Kong based enterprise listed on NASDAQ, specializes in artificial intelligence (AI), robotics, and interior design. Through its subsidiary Axonex Intelligence Limited, the company delivers intelligent robotics and facility management solutions to enterprises, real estate, shopping centers, government agencies, and more. Mint also operates Matter International Limited, providing professional interior design and renovation services. With a focus on innovation and practical applications, Mint is committed to enhancing efficiency, safety, and quality of life across industries.About Synergy Technology Group LimitedSynergy Technology Group Limited is a Hong Kong-based technology company specializing in advanced digital twin solutions and drone flight control systems, with applications across infrastructure monitoring, utilities, and smart city ecosystems. Founded by Jiang Xiaotong, an Associate Professor at Southeast University, Synergy Technology Group Limited operates under a license from Nanjing Zhishan Intelligent Technology Research Institute Co., Ltd for the “Zhishan No-Code Digital Twin Universal Platform and related drone inspection technologies”.Forward-Looking StatementsCertain statements in this release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results disclosed in the Company’s filings with the SEC. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月12日 - (亚太商讯 via SeaPRwire.com) - Mint Incorporation Limited（"Mint"或"集团"，纳斯达克股票代码：MIMI）─ 一家专注于人工智能与机械人技术，同时提供商业室内设计及装修服务的香港本地企业，今日欣然宣布，其全资子公司 Axonex Intelligence Limited （"AXONEX"）已与互惠智科有限公司（"互惠智科"）订立合资协议，共同成立Axonex Automation Limited（"合资企业"），一家总部位于香港，专注香港及特定海外市场将先进的数字孪生及无人机飞行控制技术商业化的新合资企业。根据合资协议，AXONEX将持有Axonex Automation Limited 80%的股权，而互惠智科将持有其余20%。这合资协议将结合AXONEX的营运资源与国际业务能力，及互惠智科在数字孪生与无人机飞行控制系统领域的成熟技术，以推动在基础设施检测、公用事业、智慧城市及工业营运等领域的可规模化部署。AXONEX 已承诺按阶段向合资企业投入最高达20,000,000港元的资金，具体金额将按协议所订明的业务及技术里程碑的达成情况而拟定。相关资金预计将于12至24个月期间内分四期拨付。互惠智科将向合资企业提供技术、知识产权、专业技能及持续的技术支援，初期将向Axonex Automation Limited授权其"止善零代码数字孪生通用平台"及无人机巡检相关业务。Mint董事会主席兼行政总裁陈海龙先生表示："是次与互惠智科的合资协议将创建一个平台，专注将新一代数字孪生及自动驾驶无人机技术，在香港及多个重要海外市场从概念阶段推向商业应用。"互惠智科有限公司的代表补充道："与AXONEX的合作将加速我们的数字孪生及无人机飞行控制技术在关键基础设施、智慧城市及工业应用领域的实际落地，并以香港为起点，实现全球业务拓展。"图片说明Mint董事会主席兼行政总裁陈海龙先生（右）与互惠智科创办人姜晓彤先生（左）签署合资协议，共同成立Axonex Automation Limited，专注香港及特定海外市场将先进的数字孪生及无人机飞行控制技术商业化。有关Mint Incorporation LimitedMint Incorporation Limited（纳斯达克股票代码：MIMI）是一家于纳斯达克上市的香港本地企业，专注于人工智能、机械人技术及室内设计领域。透过其子公司 Axonex Intelligence Limited，公司为企业、地产、商场、政府机构等提供智能机械人与设施管理解决方案。Mint 同时营运 Matter International Limited，提供专业室内设计与装修服务。秉持创新与实际应用并重的理念，Mint 致力于提升各行各业的效率、安全性与生活质素。有关互惠智科有限公司互惠智科有限公司是一家总部位于香港的科技企业，专门提供先进的数字孪生解决方案及无人机飞行控制系统，其应用领域涵盖基础设施监测、公共设施及智慧城市生态系统。由东南大学副教授姜晓彤创立，互惠智科有限公司获南京止善智能科技研究院有限公司所授予的许可，营运"止善零代码数字孪生通用平台"及"无人机巡检"相关业务。前瞻性陈述本新闻稿中的某些陈述属于前瞻性陈述。这些前瞻性陈述涉及已知和未知的风险和不确定性，并基于公司对可能影响其财务状况、营运成果、业务策略和财务需求的未来事件的目前期望和预测。投资者可通过"大约"、 "相信 "、 "希望 "、 "期望 "、 "预期 "、 "估计 "、"项目 "、 "打算 "、 "计划 "、 "将 "、 "将会 "、 "应该"、 "可能"或其他类似的词语或短语识别这些前瞻性陈述。公司不承担更新或修订任何前瞻性陈述以反映随后发生的事件或情况，或其期望的变化的公开义务，除非法律要求。尽管公司认为这些前瞻性陈述所表达的期望是合理的，但无法保证这些期望将会被证实正确，并提醒投资者实际结果可能与预期结果有显著差异，并鼓励投资者查阅可能影响其未来结果的其他因素，这些因素披露在公司向证券交易委员会提交的文件中。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Shantou China, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) - From March 18 to 20, 2026, the 5th China Chaoshan International Textile and Garment Exhibition will be held at the Shantou International Convention & Exhibition Center, under the theme “Five Continents Gather in Chaoshan”.This year, the Exhibition has been fully upgraded in scale, covering over 150,000 square meters and featuring more than 100 product categories. It will bring together over 1,200 exhibitors showcasing more than 200,000 new products and bestsellers, and is expected to attract over 140,000 professional buyers seeking business opportunities.The buyers come from hundreds of cities and provinces across China, as well as more than 40 countries and regions overseas, encompassing Chinese and international purchasers, both online and offline buyers. The audience spans all channels, including e-commerce shelves, livestream e-commerce, cross-border platforms, ready-to-wear brands, private domain/group purchases, overseas trade, agents/distributors, brick-and-mortar chains, supermarkets/department stores, and well-known IPsThe appeal of the Exhibition lies in the quality and quantity of professional attendees. The 5th China Chaoshan International Textile and Garment Exhibition precisely matches the product categories of exhibitors with the needs of buyers, efficiently connecting partners and attracting the top procurement representatives across key channels within the industry, offering exhibitors unprecedented business opportunities.It brings together leading internet fashion brands and buyers, such as Bananain, Beneunder, NEIWAI, and Luckymeey, who drive online market growth and provide exhibitors with a golden channel for scalable exposure and precise user reach.Top KOLs, leading MCN (Multi-Channel Network) agencies, and livestreamers will unlock traffic potential, becoming a new engine for brands to amplify both awareness and sales.Leading lingerie retail chains integrate resources to efficiently meet the end-market procurement needs, building a stable, high-end channel network and providing brands with solid market penetration capabilities.Core regional agents and channel leaders in provincial and city-level markets cultivate local distribution networks and end-market operations, helping products achieve deeper market penetration and channel expansion.The Exhibition also gathers national-level chain supermarkets, high-end department store groups, and large shopping centers, providing large-scale physical venues that lay a solid foundation for offline retail partnerships.Mainstream cross-border platforms such as Amazon, eBay, SHEIN, and TEMU, along with major international and local e-commerce sellers, will participate, opening full-chain overseas opportunities for brands and helping enterprises enter the global textile and apparel consumer market.Representatives from leading e-commerce platforms, including Alibaba, POIZON, JD.com, Douyin, and VIP.com, will attend to connect with exhibitors, sharing insights on platform traffic and algorithm trends to drive online bestsellers and omni-channel growth.Top buyers from well-known lingerie brands will serve as partners guiding professional trends. Representatives from leading lingerie brands such as Aimer, Gujin, HODO, and FENTENG will be present, providing buyers with a fast-track to the full range of lingerie products.Top buyers from apparel brands bring mature brand matrices and customer bases, providing strategic channels to expand product reach and serve as partners in market breakthroughs and value enhancement.Invitations for professional buyers to the 5th China Chaoshan International Textile and Garment Exhibition are still ongoing, helping you explore more opportunities in the industry, secure real orders, and establish meaningful partnerships. We warmly invite industry friends to join us on-site and participate in this grand event!March 18 to March 20, 2026Shantou International Convention & Exhibition CenterWe sincerely invite you to attend and explore new opportunities in the industry.Media contactCompany Name: Shantou Zhongbo Exhibition Co., Ltd.Contact Person Name: James XiaoContact Person Title: General Manager AssistantOfficial Website: www.ctge.net/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its annual results for the year ended 31 December 2025.Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG Guoxiong (center), Executive Director and Chief Executive Officer Ms. OU Haijing (left), and Chief Financial Officer Mr. KWAN Chi Fai (right)2025 Annual Results Highlights: - Overall operation remained resilient, with total revenue of RMB1,856 million (2024: RMB2,032 million).- The average financing cost was 3.61%, a three-year low; the average interest payment rate was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding exchange loss, the financing expenses decreased by approximately RMB152 million year-on-year.- As at 31 December 2025, the overall occupancy rate of the properties was 82.1% (2024: 84.5%).- Optimised the asset portfolio by disposing of a 50% interest in Yuexiu Financial Tower in Q4 2025, realising cash proceeds of approximately RMB5.3 billion to enhance financial flexibility. Yuexiu REIT maintained its "investment-grade" rating from both Standard & Poor's and Fitch, with the outlook upgraded to "stable".- The final distribution to the Unitholders for the period will be approximately RMB0.0189, equivalent to HK$0.0214. Distribution per Unit for the year will be approximately RMB0.0522, equivalent to HK$0.0580. Distribution yield is 6.74% per Unit for the year.- To maintain the REIT’s financial flexibility, the distribution ratio for the period from 1 July 2025 to 31 December 2025 has been adjusted to 90%, resulting in an overall full-year distribution ratio of approximately 96%.Guangzhou International Finance Center (GZIFC):- Operating revenue of the GZIFC complex was RMB984 million, accounting for 53.0% of the REIT’s total revenue.- The office building of GZIFC introduced two Fortune Global 500 companies; the occupancy rate was 80.9%.- GZIFC Shopping Mall introduced China Duty Free Group (CDFG), the first and currently the only downtown duty-free store in Guangzhou, achieving a renewal rate of 89% for the year, and an occupancy rate of 95.5% at the end of the period.- Four Seasons Hotel Guangzhou's average room rate increased by 5.8% year-on-year. Ascott Serviced Apartments GZIFC achieved an average occupancy rate of 91.5%, up 1 percentage point year-on-year, with revenue reaching a record high for the period.Proactive Management of Financing Risk and Effective Stabilisation of Financing Cost- With regard to the short-term loan of RMB530 million, the 5-year syndicated loan of HK$2.1 billion, and the remaining HK$2.1 billion of the 3-year syndicated loan of HK$3.8 billion, all due in 2025, the Manager in 2025 renewed the short-term loan of RMB530 million, obtained offshore loan of RMB1.7 billion, issued dim sum bonds of RMB1 billion, and obtained an offshore syndicated loan package equivalent to HK$2.1 billion (a sustainability-linked loan), for the refinancing of the maturing loans so as to ensure effective monitor on the liquidity risk.- A total of approximately RMB4.68 billion in loans were obtained in 2025 to partially refinance offshore HKD floating rate loans, taking advantage of the relatively low-cost of RMB financing to proactively adjust the financing structure. At the end of 2025, the financing interest rate exposure of Yuexiu REIT was approximately 10%, narrowed by 16 percentage points from 26% at the beginning of the year; the average financing cost was 3.61%, a three-year low, representing a decrease of 55 basis points from 4.16% at the beginning of the year; the average interest payment rate for the full year of 2025 was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding the exchange loss, the finance expenses were approximately RMB773 million, representing a year-on-year decrease of approximately RMB152 million.- As at the end of 2025, Yuexiu REIT had RMB financing of approximately RMB15.47 billion, accounting for 76% of total financing (2024: RMB financing of approximately RMB12.33 billion, accounting for 60% of total financing).Mr. JIANG Guoxiong, Chairman and Non-Executive Director of Yuexiu REIT, said, "2025 marked the 20th anniversary of Yuexiu REIT's listing. The Manager consolidated its competitive advantages by taking strategic actions to secure market share, prioritised occupancy rates, strengthened risk control to stabilise lease renewals, enhanced product competitiveness to meet market demand and invested in capital renovation projects to ensure asset value preservation and appreciation. These efforts stabilised the fundamentals of operations in a challenging market, providing solid support for the full-year revenue. Concurrently, we optimised the asset portfolio by appropriately reducing the proportion of office buildings, and proactively captured favourable financing opportunities, successfully issuing the first-ever Panda Bonds by a listed REIT globally as well as the REIT’s inaugural green bond. Financing costs for the year reached a three-year low, effectively underpinning the overall distribution level. The successful execution of a series of pioneering capital operations fully demonstrated the Manager’s strategic commitment to driving the high-quality development of Yuexiu REIT. This underscored its resolute determination in creating sustainable and long-term value for Unitholders.”Guangzhou International Finance Center (GZIFC)During the year, GZIFC recorded a newly contracted area of 15,702 sq.m. The newly launched 7,403 sq.m. of furnished units recorded an absorption cycle of about 36 days, with an absorption rate close to 72%. Quality tenants introduced include two Fortune Global 500 companies, a Fortune China 500 company, a leading global shipping giant, and a renowned Internet-based culture, sports and entertainment company. In addition, the project recorded a renewal area of 34,294 sq.m. and a renewal rate of 86%, retaining quality tenants including six Fortune Global 500 companies and a foreign consulate. GZIFC was selected as one of the Top 30 companies in the “Performance Index - 2025 Commercial Property Operation Performance)” by Guandian.GZIFC Shopping Mall renewed lease with its anchor tenant, Guangzhou Friendship Store, and introduced China Duty Free Group (CDFG) to set up a store, which is the first and currently the only downtown duty-free store in Guangzhou. In addition, GZIFC Shopping Mall launched the light meal and beverage area on the basement floor, coupled with the brand revitalisation of the dining tenants on the fourth and fifth floors by introducing seven “first stores”. Membership operations achieved remarkable results, with the share of member sales doubling to 16%. The project actively created digitalised consumption scenarios and made full use of mainstream platforms to attract customer flow through multiple channels. Specifically, the “Italian Culture Season” themed event was successfully held in collaboration with hotels, theaters, museums and consulates, effectively boosting customer flow and sales. Newly contracted area and renewal area totaled 35,573 sq.m., with a renewal rate of 89%. The occupancy rate was 95.5%.Four Seasons Hotel Guangzhou launched the first batch of renovated rooms during the year. The average room rate was RMB2,260, representing a year-on-year increase of 5.8%. The average occupancy rate was 77.7%. The revenue per available room (RevPAR) was RMB1,756, representing a year-on-year increase of 0.9%. The RevPAR competitive index was 110.0, maintaining a relatively leading market position among luxury hotel competitors. Ascott Serviced Apartments GZIFC recorded an average occupancy rate of 91.5% during the year, representing a year-on-year increase of 1 percentage point. The average room rate was RMB1,137, representing a year-on-year increase of 1.6%. The RevPAR was RMB1,040, representing a year-on-year growth of 2.7%. The RevPAR competitive index reached 146.9, remaining at a high level among high-end apartment competitors. The Apartments achieved a record high in operating revenue for the same period and ranked first in operating revenue among Ascott China properties for ten consecutive years since 2016.Yuexiu Financial TowerThe Manager disposed of 50% interest in Yuexiu Financial Tower in Q4 2025. Following completion of the disposal, Yuexiu Financial Tower became a Qualified Minority-owned Property of the REIT. The occupancy rate was 77.9% at the end of the period.White Horse BuildingWhite Horse Building introduced high-quality customers from core industrial clusters in Guangzhou, Shenzhen and Dongguan and recorded a newly contracted area of 5,808 sq.m. for the year, with full occupancy on the 1st floor for the first time in the past five years and a six-year record high set by the 2nd floor’s occupancy rate. During the year, it organised 22 original brands to showcase their products at professional exhibitions such as the Fashion World Tokyo, and the China International Fashion Fair; held the “White Horse Fashion Journey: Border Trade Supply Chain Matching Conference”, and established the “Guangdong-Xinjiang Fashion Industry Chain Supply and Procurement Cooperation Alliance” with ten wholesale markets in Urumqi, Xinjiang. During the year, it welcomed a total of 517 procurement delegations, along with nearly 13,000 purchaser visits, including 19 foreign delegations from France, Vietnam and other countries, and facilitated procurement deals worth RMB320 million. The occupancy rate was 96.0% at the end of the period.Fortune PlazaDuring the year, the project recorded a newly contracted area of 6,334 sq.m., and introduced certain quality tenants including several subsidiaries of a Fortune Global 500 integrated financial group, two Fortune Global 500 companies and the Guangzhou branch of two global leading companies. The project recorded a renewal area of 8,662 sq.m. and a renewal rate of 84.0%, retained quality tenants including three Fortune Global 500 companies and the Guangzhou branch of a national commercial bank. Upgraded product standards accelerated the absorption of vacant units, with an absorption rate of 93% for furnished units. The occupancy rate was 93.4% at the end of the period, representing a year-on-year increase of 1 percentage point, and a strong rebound of 5.4 percentage points from the interim period.City Development PlazaDuring the Reporting Year, the project recorded a newly contracted area of 9,279 sq.m. and introduced a beauty technology company and a pharmaceutical supply chain service company to enhance the ambience of healthcare business in the building. The project recorded a renewal area of 5,011 sq.m. and a renewal rate of 77%, retained tenants including a Fortune Global 500 company and a globally-renowned Contract Research Organisation (CRO). The occupancy rate was 90.6% at the end of the period.Victory PlazaVictory Plazq’s anchor tenant, Uniqlo, continued to play a flagship role, recording a 7.0% year-on-year sales growth for the year and maintaining its position as the top-selling store nationwide. The project successfully introduced the sports brand “Super Anta” to set up the largest store in the Guangzhou-Foshan region and “Crab Mang Mang”, the first store nationwide of Guizhou spicy crab business, achieved the diversification of its food and beverage brand portfolio. By connecting internal and external resources to hold fifteen major events, the mall achieved a year-on-year increase of 2.0% in its annual sales. During the year, newly contracted area and renewal area totaled 5,579 sq.m., with a renewal rate of 84%. The occupancy rate was 94.0% at the end of the period.Shanghai Yue Xiu TowerDuring the year, Shanghai Yue Xiu Tower recorded a renewal area of 6,430 sq.m., with a renewal rate of 43%, while securing a newly contracted area of 8,070 sq.m., efficiently making up for the prematurely vacated units. During the year, the project continued to increase the supply of small-area furnished units to meet market demand, formulated differentiated pricing strategies, and successfully held a channel recruitment conference, which attracted more than one hundred real estate agencies. By investing in various capital nature renovations, the project enhanced both energy efficiency and service standards. The occupancy rate was 83.1% at the end of the period.Wuhan PropertiesDuring the year, Wuhan Yuexiu Fortune Centre recorded a newly contracted area of 26,837 sq.m., and introduced quality tenants including two Fortune Global 500 state-owned enterprises, and two Fortune Global 500 foreign enterprises. In addition, it recorded a renewal area of 20,617 sq.m. and a renewal rate of 76.0%, hitting a new high in the past three years, and retained quality tenants, including seven Fortune Global 500 enterprises and a Fortune China 500 company. Approximately 21,000 sq. m. of renovated units were supplied throughout the year, with an absorption rate approaching 98%. The occupancy rate was 62.1% at the end of the period, representing a year-on-year increase of 1 percentage point.Wuhan Starry Victoria Shopping Centre revitalised several popular dining and fitness brands, aiming to attract more family and young customer groups. The project deeply tapped into the consumption potentials of “night economy” and “scene experience” by leveraging the unique venue feature of “Joy Garden”, launching themed activities such as “Riverside Starry Night ”, thus achieving customer flow substantially in line with last year, while the shopping mall recorded a year-on-year increase of 0.5% in annual sales. During the year, newly contracted area and renewal area totaled 9,827 sq.m., with a renewal rate of 48.0%. The occupancy rate was 87.4% at the end of the period, representing a rebound of 5.0 percentage points from the interim period.Hangzhou VictoryDuring the year, the project recorded a newly contracted area of 7,890 sq.m. and introduced a tenant to take up an entire floor. In addition, it recorded a renewal area of 8,836 sq.m. and a renewal rate of 54%, retained quality tenants including two Fortune Global 500 companies and the Zhejiang branch of a state-owned enterprise in Shanxi Province. The occupancy rate was 84.5% at the end of the period.Integrating ESG into Business and Promoting Sustainable DevelopmentAdhering to a long-term perspective, the Manager systematically advanced ESG initiatives. On the occasion of publicly disclosing Yuexiu REIT’s sustainability practices for the tenth consecutive year, the Manager officially renamed the “Environmental, Social and Governance Report” to the “Sustainability Report”, further promoting the deep integration of Yuexiu REIT’s strategy into sustainable development and reinforcing their synchronized progress. During the year, Yuexiu REIT received the highest Green Five Star rating and the title of “Global Sector Leader” for the first time from the Global Real Estate Sustainability Benchmark (GRESB) and once again secured A-rating (highest level) for public disclosure, highlighting its outstanding capabilities in the field of sustainable development.ProspectsIn the coming year, the Manager will maintain a prudent and optimistic attitude, adapt proactively to changes and strengthen risk managemen to generate stable return for the Unitholders. In terms of asset management, the Manager will dynamically implement proactive, prudent and flexible leasing and operating strategies in response to economic development trends and competitive dynamics, diligently explore new growth drivers, and keenly seize potential opportunities to enhance the market competitiveness of asset portfolio. In terms of financing management, the Manager will continue to review and make reasonable adjustments to its financing structure, and introduce low-cost RMB financing through various financing channels to offset interest rate risks. In respect of renovation projects, the Manager will carry out the phased renovations of Four Seasons Hotel Guangzhou in an orderly manner to support the long-term preservation and appreciation of property value.About Yuexiu Real Estate Investment TrustYuexiu Real Estate Investment Trust ("Yuexiu REIT") was listed on the Hong Kong Stock Exchange of Hong Kong Limited on 21 December 2005 and is the first listed real estate investment trust only investing in properties in the People's Republic of China (the "PRC") in the world. As of 31 December 2025, Yuexiu REIT’s portfolio of properties consisted of ten properties (including one Qualified Minority-owned Property), namely, White Horse Building, Fortune Plaza, City Development Plaza, Victory Plaza, Guangzhou International Finance Centre (“GZIFC”), Yuexiu Financial Tower (a Qualified Minority-owned Property with a 49.495% beneficial interest) located in Guangzhou; Yue Xiu Tower located in Shanghai; Wuhan Yuexiu Fortune Centre, and Starry Victoria Shopping Centre located in Wuhan; Victory Business Centre located in Hangzhou; and Yue Xiu Building located in Hong Kong. The total gross floor area of the properties (excluding Yuexiu Financial Tower) was approximately 974,000 sq.m. All properties are located in the central business district of Guangzhou, Shanghai, Wuhan, Hangzhou and Hong Kong respectively. The categories of the properties include Grade-A offices, commercial complexes, retail business, hotel, serviced apartments and professional clothing market etc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年3月11日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀（01952.HK）宣布，旗下自身免疫性疾病领域核心产品维适平(R)（精氨酸艾曲莫德片，VELSIPITY(R)）中国大陆首张处方在3月9日于中山大学附属第一医院开出，标志着这款创新疗法正式进入中国临床应用阶段。据悉，在中国大陆首方开具当天，维适平(R)已在广州、上海、杭州、西安、重庆、北京和南京7个核心城市的8家三甲医院同步开出处方，实现上市首日即覆盖全国重点区域患者，并通过互联网医院渠道进一步扩大患者覆盖范围。目前，该药物已在中山大学附属第一医院、浙江大学医学院附属邵逸夫医院、中国人民解放军空军军医大学第一附属医院、重庆市人民医院、中国医学科学院北京协和医院等多家核心医疗机构惠及患者。值得关注的是，维适平(R)于今年2月获得国家药监局批准上市，仅一个月便实现中国大陆首方落地，推进速度明显快于行业平均水平。业内认为，这不仅反映出该产品较高的临床需求，也体现了云顶新耀在创新药商业化方面的执行效率。从疾病负担来看，炎症性肠病（IBD）已被认为是全球增长最快的消化系统疾病之一。IBD主要包括溃疡性结肠炎（UC）和克罗恩病（CD）。近年来，随着饮食结构变化、生活方式改变以及诊断水平提升，中国患者数量持续增加。多家行业研究机构预计，到2030年前后，中国IBD治疗市场规模有望突破百亿元人民币，其中新型小分子创新药将成为主要增长动力之一。从临床需求来看，溃疡性结肠炎是一种病因尚不明确、易复发的慢性肠道炎症性疾病，临床表现为黏液血便、腹痛、腹泻、里急后重等症状，严重影响患者长期生活质量。近年来，中国该病发病率和患病率持续上升且呈年轻化趋势，预计患者人数将由2025年的约98万增长至2031年的约150万。目前该病仍无法治愈，患者需长期用药维持疾病控制，而传统疗法疗效有限、生物制剂存在“疗效天花板”，临床亟需能实现更稳定、持久疾病控制的创新方案。维适平(R)作为每日口服一次的新一代高选择性S1P受体调节剂，具备最佳药物（best-in-disease）潜质，已获得美国胃肠病学协会（AGA）临床实践指南与美国胃肠病学会（ACG）临床指南强烈推荐，作为中重度溃疡性结肠炎的一线用药。多项全球临床研究证实其疗效与安全性良好，尤其在快速起效、实现无激素缓解及深度黏膜愈合方面具有明显临床优势。在迄今最大规模的中重度UC患者亚洲多中心III期临床研究（ENLIGHT UC）中，维适平(R)维持治疗40周，临床缓解率达48.1%，深度黏膜愈合率达51.9%，内镜正常化率达45.5%。数据显示，维适平(R)可实现强效深度黏膜愈合，从而改善疾病长期预后，并有助于降低复发及癌变风险。全球Ⅲ期ELEVATE研究的一项开放标签扩展研究数据证实，持续维适平(R)治疗3年，在观察病例中，86.8%患者实现临床应答，临床缓解率和黏膜愈合率均维持在约60%水平。全球临床研究随访5年的数据进一步表明其稳定且良好的安全性特征，整体耐受性良好。中华医学会消化病学分会前任主任委员、中山大学附属第一医院消化内科学术带头人陈旻湖教授指出，维适平(R)此次首张处方的开具，有望进一步优化溃疡性结肠炎的临床管理路径，推动疾病治疗向更高水平发展，实现黏膜愈合的治疗目标，惠及更多患者。云顶新耀首席执行官罗永庆表示，黏膜愈合是当前溃疡性结肠炎的治疗目标，尽早实现可大幅降低患者疾病复发率、住院率、手术率和癌变风险。维适平(R)可从源头控制肠道炎症，促进黏膜愈合，填补了中重度溃疡性结肠炎治疗领域的空白。作为一款治疗溃疡性结肠炎的创新一线治疗药物，维适平(R)兼具“疗效、安全性及方便性”三重优势，为患者提供长期疾病控制与生活质量改善的保障。此外，该药物于2024年和2025年被纳入粤港澳大湾区内地9市临床急需进口港澳药品医疗器械目录，在大湾区率先实现临床应用，且在真实诊疗场景中的表现与临床研究疗效、安全性一致。商业化层面，云顶新耀已通过肾科核心产品耐赋康(R)验证了成熟可复制的商业化能力。作为全球首个且目前唯一在中、美、欧获得完全批准的IgA肾病对因治疗药物，耐赋康(R)在2025年前三季度销售额突破10亿元，创造了非肿瘤产品的历史，成为过去十年慢病药进医保销售最好的产品。该产品的成功，验证了以“科学及商业洞察驱动的准入、医学、市场、销售一体化协同（A2MS）”为核心的创新药商业化运营平台，也为后续产品的市场拓展提供了可复用的体系与经验。此次维适平(R)首方快速落地，进一步印证了该平台的高效性，依托耐赋康(R)的渠道网络与市场准入经验，其有望复刻增长路径。从市场格局来看，长期以来中国溃疡性结肠炎治疗市场以传统免疫抑制剂和注射型生物制剂为主，这些方案存在口服便利性不足、长期安全性风险等问题。维适平(R)凭借差异化优势，被业界认为有望填补这一需求缺口，行业普遍预期其销售峰值可达50亿元，成为驱动云顶新耀业绩增长的重要引擎。云顶新耀表示，将构建多渠道准入体系，提供多元化患者援助项目和创新支付方案，并全力推动维适平(R)纳入国家医保目录，以提升药物的可及性和可负担性。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com